Incidence and Management of Post-Arthroplasty Joint Infections

Authors

  • Avijit Datta Senior Resident, MS (Orthopaedic), Department of Orthopaedic, Burdwan Medical College And Hospital, Baburbag, Baburbag, Purba Bardhaman, Pin- 713104

Abstract

Introduction: Post-arthroplasty joint infection (PJI) is a serious complication following joint replacement surgeries, associated with significant morbidity, prolonged hospitalization, and increased healthcare costs. Early diagnosis and appropriate management are crucial to optimize functional outcomes and reduce implant failure. Methods: This prospective observational study was conducted in the Department of Orthopaedics at Burdwan Medical College & Hospital over a period of one year, from May 2022 to May 2023. A total of 50 adult patients undergoing primary or revision total hip and knee arthroplasty were included. Data were collected on patient demographics (age and gender), type of arthroplasty performed, risk factors for post-arthroplasty joint infection, causative organisms, and management approaches. All patients were followed postoperatively to identify the occurrence of joint infections, and appropriate interventions were recorded. The study aimed to analyze the incidence, risk factors, microbial profile, and treatment outcomes of post-arthroplasty infections in this cohort. Results: In this study of 50 patients undergoing total hip or knee arthroplasty, the majority were aged 60 years or older (60%) and male (56%), with total knee replacement being the most common procedure (70%). Post-arthroplasty joint infections occurred in 8 patients (16%). Diabetes mellitus and prolonged surgery duration (>120 minutes) were significantly associated with infection, while obesity and revision surgery showed a non-significant trend. Staphylococcus aureus was the predominant pathogen (50%), followed by coagulase-negative staphylococci and Gram-negative organisms. Management outcomes demonstrated that two-stage revision arthroplasty achieved 100% infection control, whereas debridement with implant retention was successful in 66.7% of cases. Conclusion: Post-arthroplasty joint infections, though relatively uncommon, present significant challenges in orthopedic practice. Early recognition and timely intervention tailored to infection type and patient factors are critical to improving outcomes. Multi-disciplinary approaches combining targeted antibiotic therapy and appropriate surgical intervention remain the cornerstone of effective management.

Keywords:

Post-arthroplasty infection, joint replacement, PJI, debridement, revision arthroplasty, incidence, management

References

1. Sandiford NA. The burden of prosthetic joint infection (PJI). Ann Joint. 2021;6:24.

2. Ma T, et al. Incidence of periprosthetic joint infection after primary total knee arthroplasty: a meta-analysis. J Orthop Surg Res. 2024;19(1):1.

3. Zeng ZJ, et al. Incidence of periprosthetic joint infection after primary total hip arthroplasty: a meta-analysis. J Orthop Surg Res. 2023;18(1):1.

4. Weinstein EJ, et al. Incidence of prosthetic joint infection after total knee arthroplasty. JAMA Netw Open. 2023;6(5):e2312549.

5. Hu X, et al. Diagnosis and management of prosthetic joint infection. Clin Infect Dis. 2007;56(1):e1-e10.

6. Karachalios T, et al. Management strategies for prosthetic joint infection. J Bone Joint Surg Am. 2021;103(4):e1.

7. Pellegrini A, et al. Classification and management options for prosthetic joint infection. Ann Joint. 2022;7:18.

8. Soriano A, et al. Treatment of acute post-surgical infection of joint arthroplasty. J Antimicrob Chemother. 2006;57(4):711–716.

9. Osmon DR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2012;56(1):e1-e25.

10. Bernard L, et al. Antibiotic therapy for 6 or 12 weeks for prosthetic joint infection. N Engl J Med. 2021;384(15):1427–1437.

11. Ayoade F, et al. Periprosthetic Joint Infection. StatPearls. 2023.

12. Bongartz T, et al. Incidence and Risk Factors of Prosthetic Joint Infection. J Bone Joint Surg Br. 2008;90(10):1275–1281.

13. Carender CN, et al. The Absolute versus Relative Risk of Periprosthetic Joint Infection. Arthroplasty Today. 2024;20:45-52.

14. Franceschini M, et al. Two-stage revision: indications, techniques and results. Ann Joint. 2022;7:18.

15. Hayta A, et al. Mid- to Long-Term Outcomes of Two-Stage Revision Arthroplasty. J Clin Med. 2025;14(2):547.

16. Lübbeke A, et al. Body mass and weight thresholds for increased prosthetic joint infection risk. Clin Orthop Relat Res. 2015;473(11):3514-3522.

17. Piuzzi NS, et al. Outcomes following planned two-stage exchange for prosthetic joint infection. Arch Orthop Trauma Surg. 2025;145:1123-1132.

18. Senel A, et al. Clinical and Radiological Outcomes of Two-Stage Revision Knee Arthroplasty in Infected Primary Knee Arthroplasty. Istanbul Med J. 2023;24(5):350-357.

19. Shin KH, et al. Greater Risk of Periprosthetic Joint Infection Associated with Patient Comorbidities. J Clin Med. 2024;13(11):3046.

20. Vasarhelyi EM, et al. Survivorship and Outcomes of Two-Stage Revision for Prosthetic Joint Infection. Arthroplasty Today. 2024;25:78-86.

Published

2025-09-01
Statistics
Abstract Display: 0
PDF Downloads: 0